HDL flux is higher in patients with nonalcoholic fatty liver disease (Q90020514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

title

HDL flux is higher in patients with nonalcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Chunki Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

2

Stephen F Previs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

author name string

Arthur McCullough

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Jaividhya Dasarathy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Kwangwon Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Serguei Ilchenko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Shuhui W Lorkowski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Jonathan D Smith

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Srinivasan Dasarathy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

Takhar Kasumov

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

publication date

10 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

10 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

volume

317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

E852-E862

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

In vivo metabolism of proapolipoprotein A-I in Tangier disease

10 April 2020

cites work

1 reference

12 December 2020

Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro

1 reference

12 December 2020

Relationship of the parameters of body cholesterol metabolism with plasma levels of HDL cholesterol and the major HDL apoproteins

1 reference

12 December 2020

Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice

1 reference

12 December 2020

Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects

1 reference

12 December 2020

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

1 reference

12 December 2020

The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein.

1 reference

12 December 2020

A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans

1 reference

12 December 2020

Dynamics of reverse cholesterol transport: protection against atherosclerosis

1 reference

12 December 2020

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes

1 reference

12 December 2020

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

1 reference

12 December 2020

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

1 reference

12 December 2020

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

1 reference

12 December 2020

Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver

1 reference

12 December 2020

Effects of torcetrapib in patients at high risk for coronary events

1 reference

12 December 2020

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

1 reference

12 December 2020

Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men

1 reference

12 December 2020

A comparison of 2H2O and phenylalanine flooding dose to investigate muscle protein synthesis with acute exercise in rats

1 reference

12 December 2020

Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion

1 reference

12 December 2020

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein

1 reference

12 December 2020

Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes

1 reference

12 December 2020

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

12 December 2020

Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects

1 reference

12 December 2020

Plasma proteome dynamics: analysis of lipoproteins and acute phase response proteins with 2H2O metabolic labeling

1 reference

12 December 2020

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

1 reference

12 December 2020

The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?

1 reference

12 December 2020

Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion

1 reference

12 December 2020

High-density lipoprotein function, dysfunction, and reverse cholesterol transport

1 reference

12 December 2020

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond

1 reference

12 December 2020

Assessment of cardiac proteome dynamics with heavy water: slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria.

1 reference

12 December 2020

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks

1 reference

12 December 2020

2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice

1 reference

12 December 2020

Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease

1 reference

12 December 2020

Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease

1 reference

12 December 2020

Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes

1 reference

12 December 2020

ProteomeXchange provides globally coordinated proteomics data submission and dissemination

1 reference

12 December 2020

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile

1 reference

12 December 2020

Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile

1 reference

12 December 2020

HDL cholesterol efflux capacity and incident cardiovascular events

1 reference

12 December 2020

HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export

1 reference

12 December 2020

Structural and functional changes in HDL with low grade and chronic inflammation

1 reference

12 December 2020

Internal comparison between deuterium oxide (D2O) and L-[ring-13C6] phenylalanine for acute measurement of muscle protein synthesis in humans

1 reference

12 December 2020

Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.

1 reference

12 December 2020

Dysfunctional HDL and atherosclerotic cardiovascular disease

1 reference

12 December 2020

2016 update of the PRIDE database and its related tools

1 reference

12 December 2020

Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.

1 reference

12 December 2020

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial.

1 reference

12 December 2020

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein

1 reference

12 December 2020

Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD

1 reference

12 December 2020

Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus

1 reference

12 December 2020

Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

1 reference

12 December 2020

Stable isotope-based flux studies in nonalcoholic fatty liver disease

1 reference

12 December 2020

Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.

1 reference

12 December 2020

Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.

1 reference

12 December 2020

Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?

1 reference

12 December 2020

Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease.

1 reference

12 December 2020

HDL Functionality As A New Pharmacological Target On CVD: Unifying Mechanism That Explains HDL Protection Towards The Progression Of Atherosclerosis.

1 reference

12 December 2020

10.1152/AJPENDO.00193.2019

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31503515 AND SRC:MED&resulttype=core&format=json

10 April 2020

1 reference